Susquehanna International Group’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6419 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6512 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6221 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6330 |
|
|
2023
Q1 | – | Sell |
-16
| Closed | -$2.28K | – | 6580 |
|
|
2022
Q4 | $2.28K | Sell |
16
-54
| -77% | -$7.71K | ﹤0.01% | 5624 |
|
|
2022
Q3 | $35K | Buy |
70
+20
| +40% | +$10K | ﹤0.01% | 5601 |
|
|
2022
Q2 | $43K | Buy |
50
+11
| +28% | +$9.46K | ﹤0.01% | 5271 |
|
|
2022
Q1 | $99K | Sell |
39
-12
| -24% | -$30.5K | ﹤0.01% | 5147 |
|
|
2021
Q4 | $132K | Sell |
51
-2
| -4% | -$5.18K | ﹤0.01% | 5199 |
|
|
2021
Q3 | $244K | Sell |
53
-180
| -77% | -$829K | ﹤0.01% | 4498 |
|
|
2021
Q2 | $1.61M | Sell |
233
-60
| -20% | -$413K | ﹤0.01% | 2326 |
|
|
2021
Q1 | $2.15M | Buy |
293
+211
| +257% | +$1.55M | ﹤0.01% | 2039 |
|
|
2020
Q4 | $661K | Buy |
82
+39
| +91% | +$314K | ﹤0.01% | 3091 |
|
|
2020
Q3 | $436K | Buy |
43
+4
| +10% | +$40.6K | ﹤0.01% | 3153 |
|
|
2020
Q2 | $265K | Buy |
39
+16
| +70% | +$109K | ﹤0.01% | 3488 |
|
|
2020
Q1 | $105K | Sell |
23
-40
| -63% | -$183K | ﹤0.01% | 4035 |
|
|
2019
Q4 | $380K | Sell |
63
-12
| -16% | -$72.4K | ﹤0.01% | 2927 |
|
|
2019
Q3 | $530K | Buy |
+75
| New | +$530K | ﹤0.01% | 2841 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4927 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4227 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4636 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4417 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4492 |
|